Skip to NavigationSkip to content

Pharmafile - Research and Development News

Returns R343 rights to Rigel Pharmaceuticals
Sanofi's new logo
Adopts new visual identity
Merger will create a major CRO player
Will work with Medicines for Malaria Venture in three-year deal
Will work on first-in-class inhibitor Debio 1036
Roche's Avastin (bevacizumab)
Head-to-head trial could eventually pave way for cheaper cancer drug to be used for wet AMD
Includes M&A deals at Omnicare CR and LAB Research, and Q1 financials for ICON and PPD
Snubs Valeant's hostile advances after generics giant steps in with better offer
Boehringer Ingelheim
Enrolls first patients into phase III study of its oral protease inhibitor
One of the four tofacitinib trial deaths thought to be 'study drug related'
Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches